Youth-onset type 2 diabetes in general practice: screen early, treat aggressively

Meet Kai — tired all the time

Kai is 17. He presents with tiredness that has worsened over months and is wrecking Year 12 study — he is leaning on Red Bull and coffee to get through. Last contact was around age 15 for catch-up immunisations; height and weight were recorded then, but the chart is otherwise thin. No regular medicines. Family history is loud: grandmother with type 2 diabetes in her 60s, father diagnosed in his 40s, mother had gestational diabetes while pregnant with him.

Examination: clinically stable, not dehydrated. Acanthosis nigricans on the back of his neck. Anthropometry shows about 10 kg gain over two years. Bedside work: random BGL about 10.8–14, point-of-care HbA1c 8.2%, urine dipstick negative.

What “youth-onset” means in Australia

Youth-onset type 2 diabetes is an international label. In Australia we usually break it into young adults (18–30) versus children and adolescents. Incidence is rising with obesity. Australia — especially Aboriginal and Torres Strait Islander communities — has among the highest youth-onset rates reported globally.

Who is at risk

• High prevalence in Australian Indigenous populations.
• Also elevated in Southeast Asian and Indian ethnicity.
• Clustered with lower socioeconomic status.
• Intergenerational / epigenetic cycle: maternal GDM and family type 2 program higher insulin-resistance risk in the next generation — Kai’s grandmother → father → maternal GDM is that loop in one family.

Screening guidelines (Indigenous vs non-Indigenous)

Think screening in children/adolescents and young adults 18–30. Rules differ by Indigenous status.

Additional risk factors include maternal GDM, first-degree relative with type 2, high-risk ethnicity, and signs of insulin resistance (e.g. acanthosis). Kai was overweight at 15 with several of these — an earlier screen was missed; 10 kg in two years should have brought testing forward.

Test with HbA1c or OGTT. HbA1c underestimates diabetes in youth — prefer OGTT in asymptomatic people.

Type 1 vs type 2 — do not assume by age or BMI

Being young does not equal type 1. A higher BMI does not equal type 2 — obesity is rising across ages, and type 1 increasingly presents with excess weight. History helps, but for suspected youth-onset type 2:

• Check pancreatic autoantibodies within about one month — not necessarily before you start treatment.
• C-peptide is more useful around one month than in the first week (glucose toxicity can suppress insulin early).

Kai’s antibodies were negative → new diagnosis of youth-onset type 2 diabetes.

Initial care, specialists, and the GP role

If the patient is symptomatic with a high HbA1c, insulin is needed for stabilisation. In younger patients this is often a hospital admission. Guidelines emphasise age-appropriate specialist care (e.g. paediatric diabetes clinic and multidisciplinary team). Because the disease is aggressive and pharmacotherapy under 18 is evolving, specialist access matters for disease-modifying options that may be off-label.

After stabilisation, care is typically shared between the specialist team and the GP. The GP is the consistent presence: screen, detect, refer early, coordinate, and deliver holistic / psychosocial care — not only glucose numbers.

Lifestyle baseline — but do not expect midlife-style remission

Eating pattern, less sedentary time, more activity, sleep (especially in adolescents), and reducing risky behaviours remain the foundation — HEADS/HEEADSSS assessment fits. Intensive lifestyle rarely produces the remission you sometimes see in newly diagnosed midlife type 2. Keep supporting healthy habits in a family context, and plan to step up medicines.

• Metformin is first-line medical therapy.
• Use insulin early if symptomatic or severe hyperglycaemia.
• Clinical pearl: start insulin at diagnosis if HbA1c >8.5% — a lower threshold than many midlife algorithms.

Kai’s story after hospital stabilisation: insulin weaned as metformin was titrated; whole-family lifestyle education; complication screens done; weight discussion framed for a still-growing 17-year-old.

Weight under 18 vs young adults

Under 18 (Kai)

• Whole-family approach — assess the household, not only the teen.
• Use BMI centiles (CDC charts into late teens / around 20), not adult cut-offs alone.
• If still growing, the goal may be slowing the weight-gain trajectory rather than aggressive loss.
• Screen obesity-related comorbidities: OSA, mechanical joint issues.
• Obesity drives glucose, BP, heart, and kidney risk together — see also obesity-management.drkotha.com.

Young adults (~20+)

• Metformin remains first-line, but expect to need GLP-1 and/or SGLT2 for glucose plus cardiorenal benefit.
• Prefer those over sulphonylureas or insulin when weight and hypoglycaemia matter.
• More frequent reviews — rapid beta-cell decline; catch failure early.
• At the time of the talk, TGA registration under 18: metformin, insulin, SGLT2 (dapagliflozin). Specialist involvement helps with off-label disease-modifying agents.
• Absolute CV risk calculators do not apply — treat lipids and BP earlier and more aggressively.
• Plan life transitions: school → further study/work, driving, contraception and pregnancy planning.
• Diabetes distress and stigma are high in youth type 2 — treat the person in family and culture context.

Heuristic for ethnicity: adult BMI obesity cut-offs are often lower for Asian ethnicity; childhood CDC charts do not provide ethnicity-specific centiles — apply clinical judgement rather than a black-and-white cut-off.

Five takeaways

1. Look for it — prevalence is rising; Australia’s Indigenous burden is especially high.
2. Find it early by risk, not symptoms — screen with the Indigenous / non-Indigenous rules; prefer OGTT when asymptomatic.
3. Treat it seriously and aggressively — not mild young adult T2DM; insulin sooner; avoid inertia.
4. Treat the person in family, culture, and mental-health context — distress and stigma are real.
5. Think prevention across generations — better antenatal care can change the baby’s insulin-resistance trajectory.

Bottom line from the stage: youth-onset type 2 is a more aggressive disease with poorer treatment response — so you must be more assertive to protect quality of life and life-years.

All Dr Kotha CPD pages · youth-onset-diabetes.drkotha.com · azure theme